Introduction {#Sec1}
============

The FORE-SIGHT^TM^ monitor measures absolute cerebral tissue oxygen saturation (S~ct~O~2~) of the frontal lobes of the brain, in a non-invasive way, through near-infrared spectroscopy (NIRS) \[[@CR1]\]. Its value for early detection of hemodynamic deterioration in the postoperative phase after congenital cardiac surgery has never been examined. In a prospective observational study \[2\], 300 mechanically ventilated patients younger than 12 years after cardiac surgery will be monitored with NIRS, in addition to their routine haemodynamic monitoring. The NIRS monitor is blinded to clinicians, and its predictive value to detect predefined critical hemodynamic events will be analysed.

Objectives {#Sec2}
==========

To compare S~ct~O~2~ in relationship to the arterial oxygen saturation (S~a~O~2~) and central venous oxygen saturations (S~cv~O~2~), in children with cyanotic (CC) and non-cyanotic cardiopathy (NCC) admitted to the paediatric intensive care unit (PICU) after congenital cardiac surgery.

Methods {#Sec3}
=======

The present study is a preliminary report of baseline data and monitored values of the first 136 children included in the abovementioned prospective observational FORE-SIGHT^TM^ study.

Results {#Sec4}
=======

The results are summarized in table [1](#Tab1){ref-type="table"} and table [2](#Tab2){ref-type="table"}. 83 children were admitted with a CC, 53 with NCC, and 57.3% were boys. Patients in the CC-subgroup had a longer median PICU length of stay, had lower mean arterial blood pressures, and higher haemoglobin levels compared to patients in the NCC-subgroup. Evidently, CC-patients had a lower mean S~a~O~2~. There was a non-significant trend towards lower S~cv~O~2~ and S~ct~O~2~ values in the CC subgroup (which was significant for L- S~ct~O~2~). S~cv~O~2~ was significantly lower than S~ct~O~2~ in the CC-subgroup (p=0.002), but not in the NCC-subgroup (p=0.28).Table 1OverallCyanogenicNon-Cyanogenicp-value (\*)Number (boy/girl ratio)136 (57.3%)83 (56.6%)53 (58.5%)Age in months: median (IQR)5.5 (2-18.5)5 (2-19.8)6 (2-17)0.61PICU LOS in days: median (IQR)5 (3-9)6 (4-12)3 (2-6)0.0004Hemoglobin (g/dl)10.9 (1.2)11.1 (1.2)10.5 (1.1)0.005Mean arterial pressure (mmHg)63.7 (9.6)61.7 (9.5)66.8 (9.1)0.003Mean and SD was reported, except for age and ICU LOS. (\*) P-value of the comparison of the cyanogenic and non-cyanogenic groups. T-test was used to compare means, Wilcoxon ranking-test for medians.Table 2OverallCyanogenicNon-Cyanogenicp-value (\*)SaO2 (%)92.7 (7.4)90.7 (8.0)95.7 (4.9)\< \<0.0001ScvO2 (%)67.3 (12.7)65.5 (11.9)70.8 (13.7)0.07L-SctO2 (%)71.6 (7.2)70.6 (7.8)73.1 (5.9)0.04R-SctO2 (%)71.3 (6.9)70.5 (7.7)72.6 (5.2)0.08A-SctO2 (%)71.7 (6.5)70.8 (7.3)73.1 (4.8)0.06ScvO2 \< A-SctO2p=0.002p = 0.28Mean and SD was reported, except for age and ICU LOS. (\*) P-value of the comparison of the cyanogenic and non-cyanogenic groups. T-test was used to compare means, Wilcoxon ranking-test for medians.

Conclusions {#Sec5}
===========

Notwithstanding the lower observed S~a~O~2~, CC patients are able to preserve brain tissue oxygenation as measured by NIRS, which is significantly higher than their S~cv~O~2~. The additional predictive value of NIRS in this setting will be assessed in the ongoing Fore-sight study.

Trial Registration {#Sec6}
==================

Clinical trial registered with www.clinicaltrials.gov (NCT01706497).
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